CBD Oil has been a hot topic as of late, with many people claiming that it is the cure for everything. It’s no wonder why CBD Oil has become so popular- there are so many different uses for it! As always, we must be cautious when trying new things and make sure we do our research before starting any treatment. You can get all the information from CBD Queen.
Cbd-based products are widespread: from oils to be taken in drops to vape solutions and cosmetic creams. The potential of this substance, which has already become a drug, is enormous. But studies and more precise regulation are still needed.
Scientific studies. Organic, natural products, without GMOs, pesticides or pollutants. It was analyzed in the laboratory. The presentation of cannabidiol-based products ( CBD ) by the various online retailers is so well seasoned – medically speaking – to leave you speechless or raise your eyebrow.
It sounds too immeasurable to be true: a natural, safe, relaxing, anti-inflammatory, pain reliever, calming product, suitable for insomnia, depression and even multiple sclerosis. All in one substance, cannabidiol, an ingredient extracted from cannabis (among the hundreds of active compounds that can be derived from the substance) and which can be taken in practically any form, in varying percentages: it can be vaped, ingested as drops or capsules, drained into beers and cocktails, spread in creams, because the fashion of CBD has also conquered the cosmetics sector, making proselytes.
CBD, where do we put it?
The World Health Organization (WHO) itself, through the group of experts of the ECDD (Expert Committee on Drug Dependence), called to review cannabis and derived products. The purpose of the work of the experts, Giuseppe Cannazza, pharmaceutical chemist expert in cannabis, from the University of Modena and Reggio Emilia participated in the work, tells Wired.
It was also to understand what place to give to cannabis and derived products (therefore also the cannabidiol ) within the Single Convention on narcotic drugs of 1961 of the United Nations. This international agreement prohibits producing and selling narcotic substances and drugs with similar effects, except for medical and research purposes. Within the Convention, various annexes classify the dangerousness, the risk of abuse and the therapeutic potential of the substances.
CBD, promises and scientific evidence
Outside of regulatory issues, the potential of CBD is natural, experts recall. But from here, to make it a panacea against all evil, we run. To date, for the CBD, we are moving on the front of the potential, with studies underway in various therapeutic areas. “Some suggest that it may have an anti-inflammatory, neuroprotective, pain-relieving and anxiolytic effect”, Cannazza goes on, ” but we are talking about clues, of evidence obtained above all in the preclinical field, on animal models”.
Evidence for humans is still weak. One review summed upon the matter at the beginning of February 2019. We do not know if what has been observed translates into tangible and quantifiable benefits for human health. Drug interactions cannot be excluded, and sleepiness and gastrointestinal problems have been reported. The expectations perhaps for cannabidiol, the experts reiterate, are too high at the moment.
In other words, we have no evidence comparable to those that led to the entry into the market of drugs with CBD, such as Sativex against muscular symptoms in the neurological field (where CBD is found together with THC) or anti-epileptic Epidiolex based on CBD, in the USA. ” CBD, as well as other compounds extracted from cannabis, has a perfect therapeutic profile, which bodes well, perhaps due to its activity on the endocannabinoid system, so widespread in our body. “Let’s not forget that CBD is a biologically active compound.